Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (291-300 of 403) with videos related to

Pageof 41
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and PlerixaforRaphael Teipel, Uta Oelschlägel, Katrin Wetzko, et al.
Blood|April 5, 2003
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsMartin Bornhauser, Barry Storer, John T Slattery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.
Oncotarget|February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cellsDominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Blood|May 6, 2010
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, Christian Thiede, Martin Gramatzki, et al.
Oncotarget|April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Oncoimmunology|October 25, 2019
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCARClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
Blood|September 4, 2004
Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)Thomas Kindler, Frank Breitenbuecher, Stefan Kasper, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]Ute Kossak-Roth, Susanne Saußele, Carlo Aul, et al.
Pageof 41

Showing results (291-300 of 403) with videos related to

Sort By:
Pageof 41
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and PlerixaforRaphael Teipel, Uta Oelschlägel, Katrin Wetzko, et al.
Blood|April 5, 2003
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsMartin Bornhauser, Barry Storer, John T Slattery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.
Oncotarget|February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cellsDominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Blood|May 6, 2010
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, Christian Thiede, Martin Gramatzki, et al.
Oncotarget|April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Oncoimmunology|October 25, 2019
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCARClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
Blood|September 4, 2004
Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)Thomas Kindler, Frank Breitenbuecher, Stefan Kasper, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]Ute Kossak-Roth, Susanne Saußele, Carlo Aul, et al.
Pageof 41